Trial Site Detail

 

Drug:
Imatinib
Trial:
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST) (SSGXVIII/AIO)
Conditions: GIST Sarcoma
Trial Status:
Completed

 

Lund University Hospital

     
Lund , SE-221 85
Sweden

 

Principal Investigator:
Thor Alvegard, M.D.
Contact:
Contact: Thor AlvegÄrd, M.D. +46-46-17 75 55 thor.alvegard@cancerepid.lu.se Contact: Henrik Bauer, M.D. +46-8-51772671 henrik.bauer@karolinska.se
Activation Status of this Site:
Closed
Notes about this Site:
Lund University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.